Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$719000.0.

  • Health Catalyst's Free Cash Flow fell 11306.56% to -$719000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 47256.53%. This contributed to the annual value of $12.9 million for FY2024, which is 13771.71% up from last year.
  • Health Catalyst's Free Cash Flow amounted to -$719000.0 in Q3 2025, which was down 11306.56% from -$8.8 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Free Cash Flow ranged from a high of $10.1 million in Q1 2024 and a low of -$19.3 million during Q4 2023
  • Over the past 5 years, Health Catalyst's median Free Cash Flow value was -$7.0 million (recorded in 2021), while the average stood at -$5.4 million.
  • As far as peak fluctuations go, Health Catalyst's Free Cash Flow tumbled by 84875.31% in 2023, and later skyrocketed by 26749.38% in 2024.
  • Health Catalyst's Free Cash Flow (Quarter) stood at -$10.4 million in 2021, then tumbled by 46.53% to -$15.2 million in 2022, then fell by 26.65% to -$19.3 million in 2023, then soared by 79.58% to -$3.9 million in 2024, then skyrocketed by 81.75% to -$719000.0 in 2025.
  • Its last three reported values are -$719000.0 in Q3 2025, -$8.8 million for Q2 2025, and -$390000.0 during Q1 2025.